SLS logo

SLS
SELLAS Life Sciences Group Inc

56,225
Mkt Cap
$1.73B
Volume
25.87M
52W High
$9.51
52W Low
$1.39
PE Ratio
-40.76
SLS Fundamentals
Price
$9.31
Prev Close
$9.18
Open
$9.20
50D MA
$5.58
Beta
0.84
Avg. Volume
4.58M
EPS (Annual)
-$0.2463
P/B
15.72
Rev/Employee
$0.00
$340.23
Loading...
Loading...
News
all
press releases
SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout
CEO Angelos Stergiou said the trial's extended duration suggests patients are living longer than originally projected and said the company remains "very bullish."
Stocktwits
News Placeholder
More News
News Placeholder
SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS
Sellas believes GPS-treated AML patients could live longer than those receiving standard treatment, with a projected survival of about 12.6 months versus 8 months.
Stocktwits
News Placeholder
SLS Stock Surges Toward Fifth Weekly Rise: CEO Touts GPS As Lifeline For Elderly Patients As Cancer Summit Looms
Sellas will participate Wednesday in TD Cowen’s Oncology Innovation Summit, marking the final major conference appearance ahead of the Regal data release.
Stocktwits
News Placeholder
SLS Stock Heads For Its Best Month This Year Ahead Of Key AML Trial Readout
The company plans to move quickly toward a pre-BLA meeting with the FDA and a potential filing if the REGAL trial reports positive results.
Stocktwits
News Placeholder
SLS Stock Tanks Hard: Retail Traders Blame Warrant Holders, 'Flippers' Cashing Out Before AML Catalyst
Retail speculation intensified as short interest in SLS climbed to a record high of 30.7% ahead of the final Regal catalyst.
Stocktwits
News Placeholder
SLS Stock Hits Over 4-Year High: CEO Eyes FDA Talks, ‘Whole Gamut’ Of Cancer Uses For GPS
Beyond leukemia, Sellas said GPS could potentially expand into up to 20 different tumor types.
Stocktwits
News Placeholder
Why Did ARM, SLS, EBAY Stocks Surge To 52-Week Highs?
Arm Holdings surged more than 15%, while Sellas Life Sciences rallied by over 18% and eBay climbed up 4% at close.
Stocktwits
News Placeholder
Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation
Emerging biotech and biologics names exploded onto traders’ radar Wednesday as a wave of clinical milestones, regulatory momentum, strategic acquisitions, and high-volume technical breakouts fueled aggressive speculation across the sector. $HCWB, $TGNT, $KBLB, $SLS, $RKDA, $ROIV, $SLXN
24-7 Market News
News Placeholder
SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move?
Sellas Life Sciences shares are rising Wednesday after its latest update on acute myeloid leukemia pipeline and Phase 3 readout timeline.read more...
Benzinga
News Placeholder
Nasdaq, S&P 500 Futures Higher As Nvidia Earnings Take Center Stage: Why TSLA, SLS, IBRX, CAVA, POET, BA Are Keeping Traders Engaged Today
Data from Stocktwits shows that retail sentiment continues to lean optimistic on SPY and QQQ.
Stocktwits
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available